Overview
Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease (PCWH) is an extremely rare and severe neurocristopathy caused by mutations in the SOX10 gene. It is considered a complex variant of Waardenburg-Shah syndrome (Waardenburg syndrome type 4C) and combines features of four distinct conditions. The disorder affects multiple body systems derived from neural crest cells, including the peripheral nervous system, central nervous system, skin and hair pigmentation, the inner ear, and the enteric nervous system of the gastrointestinal tract. Key clinical features include peripheral demyelinating neuropathy (damage to the myelin sheath of peripheral nerves causing weakness and sensory loss), central dysmyelinating leukodystrophy (abnormal formation of myelin in the brain and spinal cord leading to neurological impairment), features of Waardenburg syndrome (sensorineural hearing loss, heterochromia iridis, white forelock, and other pigmentary abnormalities), and Hirschsprung disease (absence of ganglion cells in segments of the colon causing functional bowel obstruction). Patients typically present in the neonatal period with a combination of these features, and the neurological involvement tends to be progressive and severe. There is currently no cure or disease-specific therapy for PCWH. Management is supportive and multidisciplinary, involving surgical intervention for Hirschsprung disease (such as pull-through procedures), hearing aids or cochlear implants for sensorineural deafness, physical therapy and rehabilitation for neuropathy, and neurological monitoring for central nervous system involvement. Genetic counseling is recommended for affected families. The prognosis varies but is generally guarded due to the severity of neurological complications.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease.
Community
No community posts yet. Be the first to share your experience with Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease.
Start the conversation →Latest news about Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease
No recent news articles for Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease
What is Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease?
Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease (PCWH) is an extremely rare and severe neurocristopathy caused by mutations in the SOX10 gene. It is considered a complex variant of Waardenburg-Shah syndrome (Waardenburg syndrome type 4C) and combines features of four distinct conditions. The disorder affects multiple body systems derived from neural crest cells, including the peripheral nervous system, central nervous system, skin and hair pigmentation, the inner ear, and the enteric nervous system of the gastrointestinal trac
How is Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease inherited?
Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease typically begin?
Typical onset of Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease is neonatal. Age of onset can vary across affected individuals.